Lastly, recent evidence shows that the ABL kinases, ABL1 and ABL2, enhance lung and breast cancer metastasis by promoting TAZ activity, and that knockout or inhibition of ABL kinases prevents metastasis [121,123]. Here, ABL1 is linked to breast carcinoma.